Medipass short-listed at Mount Vernon MES

July 2011
Medipass has been short-listed for the prestigious Mount Vernon Cancer Center MES project in North London. The 15-year contract will provide a replacement programme for the 9 linear accelerators and the cyber knife currently at the centre. It will include all maintenance, training and related services.

Medipass signs first Proton Therapy deal

July 2011
Medipass has signed the deal for the provision of the first Proton Therapy facility in Italy. The scheme is valued at over €100m. Medipass has been involved form the design stage of the project and will operate the facility with over 100 Medipass staff based on site. This prestigious project is a consortium venture working closely with Varian Medical Systems, the leading manufacturer of radiotherapy equipment.

15 Year Radiotherapy deal signed for new oncology centre

July 2011 An exciting deal to provide radiotherapy equipment to the new oncology hospital at Nanded in India has been signed by Medipass’s Indian subsidiary, Clearmedi. The linear accelerator will be the first machine within a 200km radius significantly improving prospects for a population of over 7 million people.

Medipass expands UK team with experienced radiographer

June 2011
Medipass are delighted that qualified radiographer Stephanie Elliott has joined the UK MES team. Stephanie brings with her a wealth of experience having previously worked for Leeds Teaching Hospitals NHS Trust as the equipment lead on the new oncology wing project. This MES project included;

Radiology: 2 x MRI, 3 x CT, 5 x Gamma Cameras, 2 x X-ray, digital chest room, 7 x ultrasound, 1 x fluoroscopy, 1 x interventional imaging.

Radiotherapy: 10 linear accelerators, 4 x CT sims, HDR brachytherapy unit, orthovoltage unit.

Medipass short-listed at North Middlesex University Hospital NHS Trust

June 2011
Medipass have been shortlisted for the radiotherapy MES project at North Middlesex University Hospital in London. This scheme includes 3 linear accelerators, with a rolling replacement plan including turnkey build works. The scheme also includes CT and an orthovoltage unit

KOS - financial release

March 2011
in first quarter revenues at €87 million, ebitda at €12.1 million, NET income at €2.8 million

CIR - financial release

March 2011
Revenues: €1.115 billion (+1% €1.104 billion in Q1 2010), ebitda €124.9 million (+85.3% from €67.4 million in Q1 2010)

Elekta Synergy ordered for new IMRT centre

February 2011
Medipass has confirmed the decision to order an Elekta Synergy for the 14-year project at Jindal Institute of Cancer & Research. This state of the art equipment includes 6 electron and 3 photon energies. It is using MOSAIQ and Oncentra TPS.